Viewing Study NCT03570892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2026-01-31 @ 11:45 AM
Study NCT ID: NCT03570892
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2018-06-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tisagenlecleucel View
None Non-Hodgkin's Lympoma View
None B-Cell Lymphoma View
None Diffuse Large B-cell Lymphoma View
None High Grade B-cell Lymphoma View
None Follicular Lymphoma grade 3B View
None CAR-T View
None Kymriah View
None Immunotherapy View
None Cellular therapy View
None CTL019 View